Faes Farma Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| ARGX | argenx | Outperform |
4
|
344.90€ | 531.81€ | 26.53% | 10 | 20.50€B |
| GMAB | Genmab A/S | Outperform |
16
|
kr2.03k | kr2.71k | 30.31% | 14 | kr130.86B |
| REC | Recordati Industria Chimica e ... | Hold |
18
|
50.80€ | 48.61€ | 1.28% | 1 | 10.36€B |
| ZEAL | Zealand Pharma A/S | Outperform |
8
|
kr618.50 | kr357.00 | 31.77% | 2 | kr38.52B |
| HIK | Hikma Pharmaceuticals PLC | Outperform |
18
|
£19.83 | £28.11 | 47.30% | 9 | £4.42B |
| ORNBV | Orion Oyj | Hold |
14
|
37.71€ | 42.52€ | 11.38% | 3 | 5.12€B |
| ALK B | ALK-Abelló A/S | Outperform |
13
|
kr155.90 | kr109.25 | 5.84% | 3 | kr33.91B |
| MOR | MorphoSys | Hold |
6
|
69.05€ | 28.78€ | -1.52% | 3 | 2.52€B |
| BHC | Bausch Health Companies | Hold |
15
|
$7.07 | $9.50 | 34.37% | 5 | $2.55B |
| INDV | Indivior PLC | Buy |
14
|
£13.52 | £28.89 | 128.77% | 4 | £1.95B |
| ALM | Almirall | Outperform |
16
|
9.51€ | 11.39€ | 15.67% | 3 | 1.94€B |
| EVT | Evotec | Outperform |
14
|
10.27€ | 37.33€ | 65.53% | 4 | 1.73€B |
| COPN | Cosmo Pharmaceuticals N.V. | Buy |
12
|
CHF73.50 | CHF76.55 | 27.29% | 0 | CHF1.14B |
| PHM | Pharma Mar | Outperform |
13
|
36.24€ | 50.20€ | 32.45% | 1 | 536.95€M |
| BSLN | Basilea Pharmaceutica | Outperform |
6
|
CHF44.30 | CHF65.63 | 48.98% | 0 | CHF529.94M |
| DBV | DBV Technologies | Outperform |
5
|
1.30€ | 4.07€ | 207.69% | 1 | 115.65€M |
| MOLN | Molecular Partners | Outperform |
4
|
CHF3.42 | CHF9.50 | 173.39% | 1 | CHF110.77M |